Clinical trials recruiting for Hepatitis B
147
Recruiting trials
22
US states with sites
33
Countries
18%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Peg-IFNα | 6 |
| AHB-137 | 5 |
| Entecavir | 4 |
| HepB mAb19 | 3 |
| AHB-171 Injection | 2 |
| Anti-PD-1 antibody | 2 |
| GST-HG131 | 2 |
| GST-HG141 | 2 |
| HRS-5635 Injection | 2 |
| NAs | 2 |
| SCG101 | 2 |
| Tenofovir Disoproxil Fumarate | 2 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 7 |
| New York | 7 |
| California | 6 |
| Texas | 4 |
| Virginia | 4 |
| Minnesota | 3 |
| North Carolina | 3 |
| Florida | 2 |
| Massachusetts | 2 |
| Michigan | 2 |
| Ohio | 2 |
| Arizona | 1 |
Top cities
Baltimore, Maryland 5New York, New York 5Richmond, Virginia 4Ann Arbor, Michigan 2Bethesda, Maryland 2Boston, Massachusetts 2Cleveland, Ohio 2Dallas, Texas 2Los Angeles, California 2Miami, Florida 2
Self-screener
Recruiting trials
- "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
- "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
- A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
- A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
- A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
- A Non-interventional Registry for Patients with Hepatitis B Virus Infection
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
- A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
- A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B
- A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants
- A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
- A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.
- A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
- A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B
- A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
- A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
- A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma
- A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults
- A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B
- A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
- A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
- A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
- A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
- A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
- A Trial to Evaluate the Efficacy and Safety of WGc0201 in Patients With Chronic Hepatitis B Virus Infection
- ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
- ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
- Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer
- Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable Populations, in Non-conventional Structures "Outside the Walls" by Dual Screening Method RTDs and FibroScan®
- Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
- Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384
- Adaptability of an Undetectable = Untransmissible Model for HBV
- Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
- Antiviral Therapy for Patients With Liver Cancer After Surgery
- Assessment of Treatment Adherence and Associated Factors in Chronic HepB Patients Supported by HBVCare
- Blood Collection Biorepository for Liver Disease Research
- Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
- Clinical Outcomes of HBeAg-negative CHB Patients With Indeterminate Phase
- Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
- Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis
- Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
- Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
- Combined Use of Bacteroides Fragilis and BCAAs on HBsAg Clearance
- Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
- Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
- Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure.
- D-SOLVE Cohorts (Cohort a and B)
- DELTA DESCRIBE: the French Collaborative Project
- Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia
- Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）
- Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B
- Efficacy of Tenofovir Disoproxil on Mother-to-child Transmission of HBV in Tokombéré, Cameroon in Pregnant Women
- Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
- Evaluation of Patients With Liver Disease
- Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
- Fine Needle Aspiration (FNA) Evaluation of the Intrahepatic HBV Reservoir and Its Immunological Characteristics in Chronically HBV-infected Patients
- Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease
- From Fungus to Virus, Investigating the Safety and Efficacy of Terbinafine in Chronic Hepatitis B Patients
- Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients
- Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation
- HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
- HBsAg Declined Patients Follow-up Study
- Hep Mec Cohort in Zambia
- HepB mAb19 in Individuals With Chronic Hepatitis B Infection
- Hepatitis B Vaccination After Neonatal Surgery
- Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
- Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
- Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
- Immune Dynamics in the Natural History of Chronic HBV Infection
- Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
- Impact of Hepatitis B Virus on Inflammatory Bowel Disease
- Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion
- Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B
- Liver Cancer Disparities in American Indian and Alaska Native Persons
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- Liver Disease and Other Systemic Diseases
- Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
- Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
- Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
- Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure
- MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B
- Methylene Blue Treatment of Chronic Hepatitis B Virus Infection
- Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance
- National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
- National Liver Cancer Screening Trial
- New HBV Infection Biomarkers: Clinical Characterization and Impact on Management
- Non-Invasive Model for Fibrosis Regression in HBV Patients
- Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
- Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.
- Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
- Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
- Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC
- Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
Related conditions
Trials recruiting for Hepatitis B often also study these conditions. Each links to its own recruiting-trial list.
Chronic hepatitis B 44HEPATITIS B CHRONIC 16HIV 599NASH 218Hepatocellular carcinoma 51Hepatitis C 10Hepatitis B Virus Infection 5HBV 6Cirrhosis, Liver 13Cirrhosis 29
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hepatitis B trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.